RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) yesterday and set a price target of ...

RBC Capital Markets adjusted its outlook on Gilead Sciences (NASDAQ:GILD) stock, increasing the price target to $90 from the previous $84 while maintaining a Sector Perform rating. The adjustment ...

RBC Capital Markets adjusted its price target for Fidelity National Information Services (NYSE:FIS), a leading provider of ...

RBC Bearings RBC -0.94% Get Free Report has outperformed the market over the past 15 years by 7.32% on an annualized basis producing an average annual return of 19.33%. Currently, RBC Bearings has a ...

RBC Capital analyst Brad Erickson reiterated a Buy rating on Zillow Group Class A (ZG – Research Report) today and set a price target of ...

Shares of RBC Bearings Incorporated (NYSE:RBC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight analysts that are currently covering the firm, Marketbeat reports.

William Blair has a “Outperform” rating on the stock. The consensus estimate for RBC Bearings’ current full-year earnings is $8.91 per share. William Blair also issued estimates for RBC ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...

Following the announcement, RBC Bearings' stock surged by 10.39%, closing at $355.48, reflecting a significant positive market reaction. According to InvestingPro data, the company now commands a ...